Skip to main content
. 2019 Oct 17;96(2):E110–E118. doi: 10.1002/ccd.28536

Figure 1.

Figure 1

Main clinical endpoint target vessel failure and components at 3‐year follow‐up. HbA1c, glycemic state based on glycated hemoglobin and fasting plasma glucose levels; OGTT, glycemic state based on oral glucose tolerance testing